NVO

Novo Nordisk A/S

Price Chart

No historical data available

Latest Quote

$45.33

-0.28 (-0.61%)

Current Price

Previous Close	$45.61
Open	$45.28
Day High	$45.61
Day Low	$44.95
Volume	7,554,639

Fetched: 2026-08-31T20:57:21

Stock Information

Note: Financial values converted from DKK to USD

Quarterly Dividend / Yield	$1.80 / 3.94%
Shares Outstanding	3.35B
Quarterly Dividend Yield	3.94%
Quarterly Dividend	$1.80
Total Debt	$21.78B
Cash Equivalents	$6.99B
Revenue	$51.20B
Net Income	$18.10B
Sector	Healthcare
Industry	Drug Manufacturers - General
Market Cap	$200.41B
P/E Ratio	11.08
EPS (TTM)	$4.09
Exchange	NYQ

🌐 Visit Website

Recent Price History

No history data available. Data will be fetched automatically.

About Novo Nordisk A/S

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides NovoPen 6 and NovoPen Echo Plus, smart insulin pens; Dose Check, an insulin dose guidance application; growth hormone pens and injection needles; and Wegovy pill an oral glucagon-like peptide-1 (GLP-1) receptor agonist therapy for weight management. It operates in Europe, Canada, the United States, Japan, Korea, Oceania, Southeast Asia, Mainland China, Hong Kong and Taiwan, Latin America, the Middle East, and Africa. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

📰 Latest News

No news articles available at the moment. Check back later for updates on NVO.

Period:

Income Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue
Reconciled Cost Of Revenue	$9,188,496,794	$6,958,737,400	$5,590,028,370	$4,446,389,685
Cost Of Revenue	$9,188,496,794	$6,958,737,400	$5,590,028,370	$4,446,389,685
Total Revenue	$48,306,347,776	$45,389,654,937	$36,302,127,200	$27,657,706,703
Operating Revenue	$114,007,976,064	$106,371,214,253	$95,130,513,558	$71,224,135,554
Expenses
Interest Expense	$657,549,262	$256,330,114	$84,713,977	$59,080,965
Total Expenses	$28,353,549,183	$25,330,416,826	$20,269,928,960	$15,965,146,033
Other Income Expense	$947,327,330	$-165,207,884	$276,648,964	$-848,233,859
Net Non Operating Interest Income Expense	$-496,874,044	$-14,223,195	$51,578,620	$-50,015,632
Total Other Finance Cost	$37,668,023	$45,170,368	$30,790,873	$28,290,092
Interest Expense Non Operating	$657,549,262	$256,330,114	$84,713,977	$59,080,965
Operating Expense	$19,165,052,389	$18,371,679,427	$14,679,900,590	$11,518,756,348
Other Operating Expenses	$46,889,655	$328,696,482	$-18,599,563	$-161,613,011
Selling And Marketing Expense	$10,051,579,044	$9,706,314,884	$8,868,865,646	$7,223,663,950
General And Administrative Expense	$932,947,836	$824,632,733	$758,830,917	$698,186,963
Income & Earnings
Net Income From Continuing Operation Net Minority Interest	$16,010,316,401	$15,784,308,264	$13,079,556,665	$8,678,493,646
Net Interest Income	$-496,874,044	$-14,223,195	$51,578,620	$-50,015,632
Interest Income	$198,343,241	$287,277,286	$167,083,471	$37,355,425
Normalized Income	$15,264,869,005	$15,913,371,488	$12,868,629,647	$9,336,723,121
Net Income From Continuing And Discontinued Operation	$16,010,316,401	$15,784,308,264	$13,079,556,665	$8,678,493,646
Total Operating Income As Reported	$19,952,798,593	$20,059,238,110	$16,032,198,240	$11,692,560,670
Net Income Common Stockholders	$16,010,316,401	$15,784,308,264	$13,079,556,665	$8,678,493,646
Net Income	$16,010,316,401	$15,784,308,264	$13,079,556,665	$8,678,493,646
Net Income Including Noncontrolling Interests	$16,010,316,401	$15,784,308,264	$13,079,556,665	$8,678,493,646
Net Income Continuous Operations	$16,010,316,401	$15,784,308,264	$13,079,556,665	$8,678,493,646
Pretax Income	$20,403,251,879	$19,879,807,030	$16,360,425,825	$10,794,311,179
Earnings From Equity Interest	$-2,657,080	$-2,657,080	$12,660,207	$-29,540,483
Interest Income Non Operating	$198,343,241	$287,277,286	$167,083,471	$37,355,425
Operating Income	$19,952,798,593	$20,059,238,110	$16,032,198,240	$11,692,560,670
Gross Profit	$39,117,850,983	$38,430,917,537	$30,712,098,830	$23,211,317,018
Per Share
Diluted EPS	$3.60	$3.54	$2.91	$1.91
Basic EPS	$3.60	$3.54	$2.92	$1.92
Other
Tax Effect Of Unusual Items	$204,537,014	$-33,487,579	$53,061,740	$-160,463,902
Tax Rate For Calcs	$0	$0	$0	$0
Normalized EBITDA (Bullshit earnings)	$23,546,578,051	$23,285,090,075	$17,652,392,119	$12,822,757,654
Total Unusual Items	$949,984,410	$-162,550,804	$263,988,758	$-818,693,376
Total Unusual Items Excluding Goodwill	$949,984,410	$-162,550,804	$263,988,758	$-818,693,376
Reconciled Depreciation	$3,435,761,321	$2,986,402,127	$1,471,241,075	$1,150,672,134
EBITDA (Bullshit earnings)	$24,496,562,462	$23,122,539,271	$17,916,380,877	$12,004,064,278
EBIT	$21,060,801,141	$20,136,137,144	$16,445,139,802	$10,853,392,144
Diluted Average Shares	$695,170,395	$697,561,768	$702,532,071	$710,315,754
Basic Average Shares	$694,435,791	$696,139,448	$700,656,485	$708,127,570
Diluted NI Availto Com Stockholders	$16,010,316,401	$15,784,308,264	$13,079,556,665	$8,678,493,646
Tax Provision	$4,392,935,478	$4,095,498,767	$3,280,869,160	$2,115,817,532
Gain On Sale Of Security	$949,984,410	$-162,550,804	$263,988,758	$-818,693,376
Research And Development	$8,133,635,855	$7,512,035,329	$5,070,803,591	$3,758,518,446
Selling General And Administration	$10,984,526,879	$10,530,947,616	$9,627,696,562	$7,921,850,913
Other Gand A	$932,947,836	$824,632,733	$758,830,917	$698,186,963

Fetched: 2026-08-23

Balance Sheet (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Assets
Net Tangible Assets	$10,002,188,607	$5,105,501,935	$7,213,973,422	$5,087,058,671
Total Assets	$84,854,958,263	$72,777,433,526	$49,153,800,141	$37,708,191,654
Total Non Current Assets	$57,900,752,684	$47,490,155,182	$27,327,290,934	$20,797,593,878
Non Current Deferred Assets	$3,695,998,906	$3,852,454,055	$3,185,370,563	$2,173,179,210
Non Current Deferred Taxes Assets	$3,695,998,906	$3,852,454,055	$3,185,370,563	$2,173,179,210
Non Current Accounts Receivable	$916,536,456	$627,696,182	$223,507,355	$32,197,563
Investmentin Financial Assets	$334,635,838	$355,892,481	$195,842,459	$158,799,632
Goodwill And Other Intangible Assets	$20,327,134,339	$17,321,194,856	$9,441,388,333	$7,961,707,120
Other Intangible Assets	$17,225,383,661	$14,192,560,775	$8,743,670,267	$7,240,387,927
Current Assets	$26,954,205,579	$25,287,278,344	$21,826,509,207	$16,910,597,777
Hedging Assets Current	$1,044,388,916	$988,746,525	$366,364,504	$426,226,964
Inventory	$7,756,017,834	$6,384,651,724	$4,972,022,717	$3,811,816,354
Receivables	$13,939,669,236	$13,801,969,949	$11,763,207,750	$8,987,965,369
Other Receivables	$2,107,221,096	$2,110,503,372	$1,261,019,122	$938,574,594
Taxes Receivable	$757,736,825	$445,920,619	$378,712,114	$146,920,919
Accounts Receivable	$11,074,711,316	$11,245,545,959	$10,123,476,514	$7,902,469,856
Allowance For Doubtful Accounts Receivable	$-310,565,815	$-332,447,654	$-280,400,137	$-237,574,252
Gross Accounts Receivable	$11,385,277,131	$11,577,993,613	$10,403,876,651	$8,140,044,108
Cash Cash Equivalents And Short Term Investments	$4,214,129,594	$4,111,910,146	$4,724,914,236	$3,684,589,090
Cash And Cash Equivalents	$4,136,292,766	$2,446,858,497	$2,249,453,049	$1,977,649,349
Cash Financial	$4,136,292,766	$2,446,858,497	$2,249,453,049	$1,977,649,349
Debt
Net Debt	$14,992,498,290	$12,561,113,379	$1,076,586,479	$1,344,482,708
Total Debt	$20,468,584,798	$16,065,489,895	$4,221,006,743	$4,030,009,548
Long Term Debt And Capital Lease Obligation	$18,590,341,518	$14,015,943,075	$3,208,502,793	$3,800,875,434
Long Term Debt	$17,459,363,039	$13,167,552,917	$2,497,030,428	$3,247,108,609
Current Debt And Capital Lease Obligation	$1,878,243,280	$2,049,546,820	$1,012,503,950	$229,134,114
Current Debt	$1,669,428,017	$1,840,418,959	$829,009,100	$75,023,448
Other Current Borrowings	$1,524,382,684	$935,136,020	$757,736,825	-
Liabilities
Total Liabilities Net Minority Interest	$54,525,635,317	$50,350,736,734	$32,498,438,386	$24,659,425,863
Total Non Current Liabilities Net Minority Interest	$20,818,069,027	$16,337,918,790	$5,981,556,990	$5,756,642,944
Tradeand Other Payables Non Current	$164,270,091	$227,571,126	$29,540,483	$15,629,885
Non Current Deferred Liabilities	$1,033,291,697	$861,988,158	$1,588,308,914	$1,103,626,180
Non Current Deferred Taxes Liabilities	$1,033,291,697	$861,988,158	$1,588,308,914	$1,103,626,180
Current Liabilities	$33,707,566,290	$34,012,817,944	$26,516,881,397	$18,902,782,919
Other Current Liabilities	$6,525,008,091	$6,705,689,562	$4,685,370,626	$4,143,326,215
Payables And Accrued Expenses	$25,245,859,149	$25,212,411,195	$5,114,410,970	$3,544,545,320
Payables	$25,245,859,149	$25,212,411,195	$5,114,410,970	$3,544,545,320
Total Tax Payable	$1,315,411,122	$1,518,599,627	$1,112,222,617	$1,108,315,145
Accounts Payable	$23,930,448,027	$23,693,811,568	$4,002,188,353	$2,436,230,175
Other Non Current Liabilities	-	$3,594,874	$29,540,483	$15,629,885
Current Notes Payable	-	-	-	$0
Equity
Common Stock Equity	$30,329,322,946	$22,426,696,791	$16,655,361,755	$13,048,765,791
Total Equity Gross Minority Interest	$30,329,322,946	$22,426,696,791	$16,655,361,755	$13,048,765,791
Stockholders Equity	$30,329,322,946	$22,426,696,791	$16,655,361,755	$13,048,765,791
Gains Losses Not Affecting Retained Earnings	$-264,926,551	$-219,756,183	$199,437,333	$382,775,884
Other Equity Adjustments	$-264,926,551	$-219,756,183	$199,437,333	$382,775,884
Retained Earnings	$30,524,852,807	$22,577,056,285	$16,386,215,135	$12,595,655,425
Long Term Equity Investment	$57,205,379	$62,519,540	$64,082,528	$51,109,724
Other
Treasury Shares Number	$3,363,654	$3,697,958	$8,082,535	$9,409,191
Ordinary Shares Number	$694,510,711	$694,176,408	$696,825,279	$703,313,565
Share Issued	$697,874,365	$697,874,365	$704,907,814	$712,722,756
Tangible Book Value	$10,002,188,607	$5,105,501,935	$7,213,973,422	$5,087,058,671
Invested Capital	$49,458,114,002	$37,434,668,667	$19,981,401,283	$16,370,897,848
Working Capital	$-6,753,360,711	$-8,725,539,600	$-4,690,372,190	$-1,992,185,142
Capital Lease Obligations	$1,339,793,742	$1,057,518,019	$894,967,215	$707,877,492
Total Capitalization	$47,788,685,985	$35,594,249,708	$19,152,392,182	$16,295,874,400
Treasury Stock	$312,598	$312,598	$781,494	$937,793
Capital Stock	$69,709,287	$69,709,287	$70,490,781	$71,272,276
Common Stock	$69,709,287	$69,709,287	$70,490,781	$71,272,276
Employee Benefits	$134,573,310	$141,137,862	$115,973,747	$119,099,724
Non Current Pension And Other Postretirement Benefit Plans	$134,573,310	$141,137,862	$115,973,747	$119,099,724
Long Term Capital Lease Obligation	$1,130,978,479	$848,390,158	$711,472,365	$553,766,826
Long Term Provisions	$895,592,410	$1,091,278,571	$1,039,231,054	$717,411,722
Current Capital Lease Obligation	$208,815,264	$209,127,861	$183,494,850	$154,110,666
Line Of Credit	$28,602,690	$70,178,184	$71,272,276	$75,023,448
Commercial Paper	$116,442,643	$835,104,756	$0	-
Current Provisions	$58,455,770	$45,170,368	$15,704,595,850	$10,985,777,270
Investments And Advances	$391,841,217	$418,412,021	$259,924,988	$209,909,356
Available For Sale Securities	$334,635,838	$355,892,481	$195,842,459	$158,799,632
Investmentsin Associatesat Cost	$57,205,379	$62,519,540	$64,082,528	$51,109,724
Goodwill	$3,101,750,678	$3,128,634,080	$697,718,066	$721,319,193
Net PPE	$32,569,241,765	$25,270,398,068	$14,217,099,695	$10,420,600,628
Accumulated Depreciation	$-9,211,629,024	$-8,189,434,545	$-7,443,263,835	$-6,995,155,032
Gross PPE	$41,780,870,789	$33,459,832,613	$21,660,363,530	$17,415,755,660
Construction In Progress	$20,416,068,385	$13,363,082,778	$6,199,281,288	$3,494,998,585
Other Properties	$1,736,949,120	$1,588,934,109	$1,403,407,374	$1,268,208,869
Machinery Furniture Equipment	$9,381,056,977	$8,915,130,105	$6,400,594,206	$5,868,709,220
Properties	$10,246,796,307	$9,592,685,620	$7,657,080,661	$6,783,838,987
Inventories Adjustments Allowances	$-884,807,790	$-582,682,113	$-392,935,309	$-268,052,528
Finished Goods	$1,874,023,211	$1,386,839,696	$1,129,102,892	$943,732,456
Work In Process	$4,041,575,663	$3,490,934,815	$2,751,016,059	$2,137,074,176
Raw Materials	$2,725,226,749	$2,089,559,326	$1,484,839,075	$999,062,249
Other Short Term Investments	$77,836,827	$1,665,051,649	$2,475,461,186	$1,706,939,741

Fetched: 2026-08-23

Cash Flow Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Free Cash Flow
Free Cash Flow	$4,530,947,363	$10,887,621,592	$10,942,795,086	$10,024,070,446
Operating Activities
Operating Cash Flow	$18,615,505,633	$18,907,159,287	$17,022,195,156	$12,329,947,380
Cash Flow From Continuing Operating Activities	$18,615,505,633	$18,907,159,287	$17,022,195,156	$12,329,947,380
Operating Gains Losses	-	$-1,723,507,419	$5,043,451,292	$21,569,241
Investing Activities
Capital Expenditure	$-14,084,558,270	$-8,019,537,695	$-6,079,400,070	$-2,305,876,934
Investing Cash Flow	$-12,372,304,368	$-20,146,140,271	$-6,860,269,124	$-3,894,654,744
Cash Flow From Continuing Investing Activities	$-12,372,304,368	$-20,146,140,271	$-6,860,269,124	$-3,894,654,744
Financing Activities
Repurchase Of Capital Stock	$-216,942,804	$-3,154,267,092	$-4,677,086,787	$-3,764,614,101
Financing Cash Flow	$-4,440,137,731	$1,365,270,455	$-9,871,522,768	$-8,095,811,533
Cash Flow From Continuing Financing Activities	$-4,440,137,731	$1,365,270,455	$-9,871,522,768	$-8,095,811,533
Cash Dividends Paid	$-8,090,497,373	$-6,899,031,239	$-4,965,145,568	$-3,954,829,802
Net Common Stock Issuance	$-216,942,804	$-3,154,267,092	$-4,677,086,787	$-3,764,614,101
Dividends Received Cfi	-	-	$0	$0
Other
Repayment Of Debt	$-12,376,993,334	$-990,153,215	$-229,290,413	$-2,129,259,234
Issuance Of Debt	$16,244,295,779	$12,408,722,000	$0	$1,752,891,603
End Cash Position	$4,136,292,766	$2,446,858,497	$2,249,453,049	$1,977,649,349
Beginning Cash Position	$2,446,858,497	$2,249,453,049	$1,977,649,349	$1,675,367,373
Effect Of Exchange Rate Changes	$-113,629,264	$71,115,977	$-18,599,563	$-37,199,126
Changes In Cash	$1,803,063,534	$126,289,471	$290,403,263	$339,481,102
Common Stock Payments	$-216,942,804	$-3,154,267,092	$-4,677,086,787	$-3,764,614,101
Net Issuance Payments Of Debt	$3,867,302,446	$11,418,568,786	$-229,290,413	$-376,367,631
Net Long Term Debt Issuance	$3,867,302,446	$11,418,568,786	$-229,290,413	$-376,367,631
Long Term Debt Payments	$-12,376,993,334	$-990,153,215	$-229,290,413	$-2,129,259,234
Long Term Debt Issuance	$16,244,295,779	$12,408,722,000	$0	$1,752,891,603
Net Investment Purchase And Sale	$1,555,329,856	$715,379,836	$-780,869,055	$-482,963,446
Sale Of Investment	$1,668,333,925	$3,812,285,250	$1,296,186,363	$1,038,605,858
Purchase Of Investment	$-113,004,069	$-3,096,905,414	$-2,077,055,418	$-1,521,569,305
Net Business Purchase And Sale	$156,924,045	$-12,841,982,413	$0	$-1,105,814,364
Sale Of Business	$156,924,045	$0	$0	-
Purchase Of Business	$0	$-12,841,982,413	$0	$-1,105,814,364
Net Intangibles Purchase And Sale	$-4,684,745,431	$-647,858,733	$-2,045,951,946	$-407,471,102
Purchase Of Intangibles	$-4,684,745,431	$-647,858,733	$-2,045,951,946	$-407,471,102
Net PPE Purchase And Sale	$-9,399,812,839	$-7,371,678,961	$-4,033,448,123	$-1,898,405,832
Purchase Of PPE	$-9,399,812,839	$-7,371,678,961	$-4,033,448,123	$-1,898,405,832
Taxes Refund Paid	$-5,003,751,384	$-4,632,072,719	$-4,047,671,318	$-2,268,677,808
Interest Received Cfo	$218,505,792	$294,467,033	$167,552,367	$43,138,483
Interest Paid Cfo	$-534,385,768	$-95,654,896	$-76,742,735	$-42,513,287
Change In Working Capital	$584,088,802	$404,657,723	$3,081,119,230	$-865,114,135
Other Non Cash Items	$-487,965,010	$69,552,988	$66,270,712	$369,959,378
Deferred Tax	$4,392,935,478	$4,095,498,767	$3,280,869,160	$2,115,817,532
Deferred Income Tax	$4,392,935,478	$4,095,498,767	$3,280,869,160	$2,115,817,532
Depreciation Amortization Depletion	$3,435,761,321	$2,986,402,127	$1,471,241,075	$1,150,672,134
Depreciation And Amortization	$3,435,761,321	$2,986,402,127	$1,471,241,075	$1,150,672,134
Depreciation	$3,435,761,321	$2,986,402,127	$1,471,241,075	$1,150,672,134
Net Income From Continuing Operations	$16,010,316,401	$15,784,308,264	$13,079,556,665	$8,678,493,646
Change In Other Working Capital	-	$392,310,114	$-193,029,080	$181,306,666
Change In Other Current Liabilities	-	$1,425,758,110	$796,967,836	$585,495,492
Change In Payables And Accrued Expense	-	$-43,763,678	$1,185,839,375	$804,939,078
Change In Payable	-	$-43,763,678	$1,185,839,375	$804,939,078
Change In Account Payable	-	$506,408,274	$1,565,958,178	$1,049,859,375
Change In Inventory	-	$-1,412,629,006	$-1,160,206,364	$-745,076,618
Change In Receivables	-	$-2,236,480,245	$-2,543,451,186	$-1,691,778,752
Changes In Account Receivables	-	$-1,122,069,444	$-2,221,006,658	$-1,550,015,695
Stock Based Compensation	-	$357,768,068	$335,886,229	$240,543,930
Provisionand Write Offof Assets	-	$3,286,964,816	$5,037,511,936	$2,886,058,265
Asset Impairment Charge	-	$1,650,828,454	-	$126,445,770
Amortization Cash Flow	-	$392,622,711	-	$249,921,861
Amortization Of Intangibles	-	$392,622,711	-	$249,921,861
Pension And Employee Benefit Expense	-	$-18,599,563	$5,039,543,821	$96,123,793
Earnings Losses From Equity Investments	-	$2,657,080	$-12,660,207	$29,540,483
Gain Loss On Investment Securities	-	$-793,841,859	$16,567,678	$402,000,642
Net Foreign Currency Exchange Gain Loss	-	$-913,723,077	$355,892,481	$-506,095,676
Sale Of PPE	-	-	-	$0

Fetched: 2026-08-23